Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT06398457
Recruiting
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Early phase 1 · United States · 1 site
Registry update: 5 Oct 2026
NCT06588413
Recruiting
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Phase 3 · United States · 1 site
Registry update: 22 Nov 2024
NCT06140524
Recruiting
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Phase 2 · Belgium, Spain, France, Ireland, Italy, Poland, United States · 40 sites
Registry update: 8 Jul 2026
NCT06698887
Recruiting
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Not applicable · South Korea · 5 sites
Registry update: 1 Oct 2026
NCT06682156
Recruiting
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
Not applicable · China · 1 site
Registry update: 12 Nov 2024
2023-510173-34-00
Recruiting
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies
Phase 3 · Belgium, Spain, Finland, Netherlands · 11 sites
Registry update: 11 Sept 2026
NCT06999031
Recruiting
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
Early phase 1 · China · 1 site
Registry update: 31 May 2025
NCT06908629
Recruiting
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Not applicable · United States · 1 site
Registry update: 26 Aug 2025
NCT06582017
Recruiting
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Phase 1 · United States · 11 sites
Registry update: 20 Oct 2026
NCT06500884
Recruiting
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Phase 2 · Brazil, Spain, United Kingdom, South Korea, Netherlands, Puerto Rico, United States · 38 sites
Registry update: 25 Sept 2026
NCT06433947
Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Phase 1 · United States · 12 sites
Registry update: 30 Oct 2026
NCT06185751
Recruiting
Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 9 Jul 2026
NCT06376526
Recruiting
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
Phase 2 · United States · 1 site
Registry update: 18 Aug 2026
NCT06484777
Recruiting
A Clinical Study of SHR-9539 in Patients With Multiple Myeloma
Phase 1 · China · 1 site
Registry update: 16 Apr 2026
NCT06292780
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Phase 1/2 · Germany, Spain, United Kingdom, Greece, South Korea, Netherlands, Taiwan, United States · 33 sites
Registry update: 18 Aug 2026
NCT06225310
Recruiting
A Trial of Selinexor, Ruxolitinib and Methylprednisolone
Phase 1 · United States · 1 site
Registry update: 16 Jan 2025
NCT06280924
Recruiting
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Not applicable · Canada · 1 site
Registry update: 23 Oct 2026
NCT06520176
Recruiting
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Phase 3 · China · 16 sites
Registry update: 25 Jul 2024
NCT06395441
Recruiting
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Phase 3 · United States · 15 sites
Registry update: 20 Oct 2026
NCT06083207
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Phase 1/2 · Australia, China · 13 sites
Registry update: 13 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.